Cargando…

Look, Ma! No pneumococcus!

Pneumococcal diseases, caused by the bacterium Streptococcus pneumoniae, include pneumonia and otitis media, which accounts for some 12 million doctor visits per year in the United States alone. Each year around the world, pneumococcus causes 1.2 million deaths due to pneumonia, 39% of which are in...

Descripción completa

Detalles Bibliográficos
Autor principal: Potera, C
Formato: Texto
Lenguaje:English
Publicado: 1999
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1566588/
https://www.ncbi.nlm.nih.gov/pubmed/10339459
_version_ 1782129651247742976
author Potera, C
author_facet Potera, C
author_sort Potera, C
collection PubMed
description Pneumococcal diseases, caused by the bacterium Streptococcus pneumoniae, include pneumonia and otitis media, which accounts for some 12 million doctor visits per year in the United States alone. Each year around the world, pneumococcus causes 1.2 million deaths due to pneumonia, 39% of which are in children under the age of five. In a three-year Phase III clinical trial involving 38,000 children, in which half of the infants received a new pneumococcal vaccine and half received a placebo vaccine, the new vaccine demonstrated an efficacy rate of 100% against bacterial meningitis and bacteremia, the two most deadly pneumococcal afflictions.
format Text
id pubmed-1566588
institution National Center for Biotechnology Information
language English
publishDate 1999
record_format MEDLINE/PubMed
spelling pubmed-15665882006-09-19 Look, Ma! No pneumococcus! Potera, C Environ Health Perspect Research Article Pneumococcal diseases, caused by the bacterium Streptococcus pneumoniae, include pneumonia and otitis media, which accounts for some 12 million doctor visits per year in the United States alone. Each year around the world, pneumococcus causes 1.2 million deaths due to pneumonia, 39% of which are in children under the age of five. In a three-year Phase III clinical trial involving 38,000 children, in which half of the infants received a new pneumococcal vaccine and half received a placebo vaccine, the new vaccine demonstrated an efficacy rate of 100% against bacterial meningitis and bacteremia, the two most deadly pneumococcal afflictions. 1999-06 /pmc/articles/PMC1566588/ /pubmed/10339459 Text en
spellingShingle Research Article
Potera, C
Look, Ma! No pneumococcus!
title Look, Ma! No pneumococcus!
title_full Look, Ma! No pneumococcus!
title_fullStr Look, Ma! No pneumococcus!
title_full_unstemmed Look, Ma! No pneumococcus!
title_short Look, Ma! No pneumococcus!
title_sort look, ma! no pneumococcus!
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1566588/
https://www.ncbi.nlm.nih.gov/pubmed/10339459
work_keys_str_mv AT poterac lookmanopneumococcus